Home » Topics » HIV/AIDS, BioWorld Science

HIV/AIDS, BioWorld Science
RSS

Merck & Co. presents HIV-1 protease inhibitors

July 20, 2018

Orion Biotechnology earns grant to support development of microbicide candidate

July 19, 2018

FDA approves Symtuza for HIV-1 infection

July 18, 2018

Chinese researchers present preclinical data for DB-213, an HIV-1 replication inhibitor

July 18, 2018

Promising data presented from completed pivotal study of PRO-140 with HAART for HIV-1

July 17, 2018

A mosaic HIV-1 vaccine is assessed in a phase I/IIa trial and in rhesus monkeys

July 17, 2018

Idenix and Merck & Co. disclose anti-HIV-1 compounds

July 16, 2018

ALVAC-HIV and bivalent subtype C gp120/MF59 HIV-1 vaccine qualifies for phase II/III testing

July 16, 2018

Matinas collaborates with NINDS to develop HIV therapy based on LNC platform

July 10, 2018

Positive topline data presented from phase IIa study of ABX-464

July 4, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...